Key result
Adding four CMR markers to clinical factors improves post-AVR mortality prediction to a ~0.78 C-index.
Why the study?
The relative prognostic power and thresholds of cardiovascular magnetic resonance markers for mortality risk stratification in aortic stenosis remain undefined.
Cohort (n=799)
Yes
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“This study is the largest multi-national, multi-center study in which T1-mapping, a new cardiac MRI technology, has been applied, among aortic stenosis studies conducted worldwide. The significance of the study is that it demonstrated myocardial fibrosis is an important risk factor for the long-term prognosis of patients with severe aortic stenosis and that the threshold value that predicts the patient's mortality from these indicators was identified for the first time”
Prospective cohort study demonstrates cardiovascular MRI markers predict post-procedure mortality in severe aortic stenosis, indicating key thresholds for intervention.
BACKGROUND Cardiovascular magnetic resonance (CMR) is increasingly used for risk stratification in aortic stenosis (AS). However, the relative prognostic power of CMR markers and their respective thresholds remains undefined. OBJECTIVES Using machine learning, the study aimed to identify prognostically important CMR markers in AS and their thresholds of mortality. METHODS Patients with severe AS undergoing AVR (n = 440, derivation; n = 359, validation cohort) were prospectively enrolled across 13 international sites (median 3.8 years' follow-up). CMR was performed shortly before surgical or transcatheter AVR. A random survival forest model was built using 29 variables (13 CMR) with post-AVR death as the outcome. RESULTS There were 52 deaths in the derivation cohort and 51 deaths in the validation cohort. The 4 most predictive CMR markers were extracellular volume fraction, late gadolinium enhancement, indexed left ventricular end-diastolic volume (LVEDVi), and right ventricular ejection fraction. Across the whole cohort and in asymptomatic patients, risk-adjusted predicted mortality increased strongly once extracellular volume fraction exceeded 27%, while late gadolinium enhancement >2% showed persistent high risk. Increased mortality was also observed with both large (LVEDVi >80 mL/m2) and small (LVEDVi ≤55 mL/m2) ventricles, and with high (>80%) and low (≤50%) right ventricular ejection fraction. The predictability was improved when these 4 markers were added to clinical factors (3-year C-index: 0.778 vs 0.739). The prognostic thresholds and risk stratification by CMR variables were reproduced in the validation cohort. CONCLUSIONS Machine learning identified myocardial fibrosis and biventricular remodeling markers as the top predictors of survival in AS and highlighted their nonlinear association with mortality. These markers may have potential in optimizing the decision of AVR.
No takes yet. Share an insight, caveat, or question.
Kwak et al. (2021) conducted a cohort in severe aortic stenosis (n=799). Cardiovascular magnetic resonance (CMR) markers (extracellular volume fraction, late gadolinium enhancement, LVEDVi, right ventricular ejection fraction) vs. Clinical factors alone was evaluated on post-AVR death. Adding four CMR markers to clinical factors improved the prediction of post-AVR mortality in patients with severe aortic stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: